STOCK TITAN

Exelixis (NASDAQ: EXEL) shares preliminary 2025 results and 2026 guidance

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Exelixis, Inc. filed a current report to disclose that on January 11, 2026 it issued a press release with preliminary, unaudited financial results for the fiscal year ended January 2, 2026. The release also provided financial guidance for the fiscal year ending January 1, 2027 and included an update on the company’s business.

The company notes that the audit of its fiscal 2025 financial statements is ongoing and could lead to changes in the information contained in the press release. Exelixis states it plans to report its audited financial results for the fiscal year ended January 2, 2026 on February 10, 2026. The press release is furnished as Exhibit 99.1 and is not deemed filed for liability purposes.

Positive

  • None.

Negative

  • None.
0000939767false00009397672026-01-112026-01-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 11, 2026

Exelixis_Logo_RGB_2023.jpg
EXELIXIS, INC.
(Exact name of registrant as specified in its charter)

Delaware
000-30235
04-3257395
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)

1851 Harbor Bay Parkway
Alameda, California 94502
(Address of principal executive offices) (Zip Code)

(650) 837-7000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock $0.001 Par Value per ShareEXELThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02. Results of Operations and Financial Condition.

On January 11, 2026, Exelixis, Inc. (Exelixis or the Company) issued a press release announcing its preliminary unaudited financial results for the fiscal year ended January 2, 2026, providing financial guidance for the fiscal year ending January 1, 2027, and delivered an update on its business. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The preliminary unaudited financial results contained in the press release do not present all information for an understanding of Exelixis’ financial condition as of January 2, 2026 and its results of operations for the fiscal year ended January 2, 2026. The audit of Exelixis’ financial statements for the fiscal year ended January 2, 2026 is ongoing and could result in changes to the information in the press release. The press release also announced that Exelixis will report its audited financial results for the fiscal year ended January 2, 2026 on February 10, 2026.

The information in this report, including the exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission (SEC) made by Exelixis, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(d)     Exhibits.

Exhibit NumberExhibit Description
99.1
Press Release dated January 11, 2026
104Cover Page Interactive Data FileThe cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EXELIXIS, INC.
January 12, 2026
/s/ Brenda Hefti
DateBrenda Hefti
Executive Vice President and General Counsel


FAQ

What did Exelixis (EXEL) disclose in this 8-K filing?

Exelixis disclosed that it issued a press release with preliminary unaudited financial results for the fiscal year ended January 2, 2026, provided financial guidance for the fiscal year ending January 1, 2027, and delivered an update on its business.

Are the financial results Exelixis (EXEL) reported audited or preliminary?

The results described are preliminary and unaudited. Exelixis notes that the audit of its financial statements for the fiscal year ended January 2, 2026 is ongoing and could result in changes to the information in the press release.

When will Exelixis (EXEL) report its audited fiscal 2025 results?

Exelixis states that it will report its audited financial results for the fiscal year ended January 2, 2026 on February 10, 2026.

What guidance did Exelixis (EXEL) provide in connection with these results?

The company states that the press release provided financial guidance for the fiscal year ending January 1, 2027, alongside preliminary results and a business update. Specific guidance figures are contained in Exhibit 99.1.

Is the Exelixis (EXEL) press release incorporated into other SEC filings?

Exelixis specifies that the information in this report and its exhibit is furnished, not filed, and will not be incorporated by reference into any other SEC filing, regardless of general incorporation language.

Where can investors find the preliminary results and guidance from Exelixis (EXEL)?

The preliminary unaudited results, financial guidance, and business update are included in the press release furnished as Exhibit 99.1 to this report.

Exelixis Inc

NASDAQ:EXEL

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

12.01B
262.25M
2.23%
96.96%
6.55%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
ALAMEDA